Testing effectiveness (Phase 2)Study completedNCT00612534
What this trial is testing
A Multicenter, Randomized, Placebo-Controlled Phase 2 Study to Evaluate the Clinical Efficacy, Safety, and Tolerability of ARX-F01 Sublingual Sufentanil in Patients Undergoing Elective Unilateral Total Knee Replacement
Who this might be right for
Post Operative Pain
Talphera, Inc 94